McIlrath & Eck’s Juno Therapeutics, Inc. JUNO Stock Holding History

McIlrath & Eck’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-119	Closed	-$5K	–	554
2017 Q4	$5K	Buy	+119	New	+$5.94K	﹤0.01%	388

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

McIlrath & Eck's JUNO Position: Q1 2018 in Review

McIlrath & Eck sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 119 shares — an estimated $5K sold.

McIlrath & Eck first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

McIlrath & Eck reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
McIlrath & Eck sold 119 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $5K.
McIlrath & Eck first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
McIlrath & Eck's Juno Therapeutics, Inc. position peaked at $5K in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on McIlrath & Eck's 13F filing for Q1 2018, filed 22 May 2018.